Drug Discovery World

APRIL 3, 2023

DS: What motivated you and Dr David Bunka, CTO, to create Aptamer and did you imagine you would one day be operating on such a global scale?    AT : We initially met at the University of Leeds, where David was a post-doctoral researcher studying aptamers, and I was completing my PhD. Optimer binders are engineered to overcome these problems.

Science 130

Science Molecular Biology Therapies Small Molecule 130

Elrig

APRIL 29, 2024

She is currently a Senior drug discovery scientist working across Cell Engineering, Cell Biology and Functional Genomics teams, using CRISPR/Cas9 and Next Generation Sequencing for target identification, target validation and drug development in the oncology disease area. big pharma or startups/spin off? What pro/cons?

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

Drug Discovery World

AUGUST 16, 2022

In recent years, governments, institutes, pharma companies, and funding bodies have taken significant measures to proactively address cancer disparities. Often, in an attempt to flag risks associated with the disease, a scoring system is used if the patient identifies with a particular race or ethnicity.

Research 130

Research Clinical Trials Trials Drug Development 130

Codon

FEBRUARY 13, 2024

alone, according to the Centers for Disease Control and Prevention. ” A Global View Even as advances in computing and molecular biology usher in the era of a new, high-tech “phage therapy 2.0”, At least a million people die from drug-resistant bacterial infections every year.

Therapies 138

Therapies DNA Virus Clinical Trials 138